Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-03

FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

The FDA approved a supplemental application for buspirone hydrochloride (Advagen Pharma Ltd), updating the approval status of this generic product under an ANDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone HCl (Buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HCL (BUSPIRONE HYDROCHLORIDE)